Linear mixed models to handle missing at random data in trial‐based economic evaluations

Quarto
R
Academia
publication
health economics
statistics
Authors
Affiliations

Catrin Plumpton

University of Bangor

Sube Banerjee

University of Plymouth

Baptiste Leurent

University College London

Published

April 10, 2022

Abstract

Trial-based cost-effectiveness analyses (CEAs) are an important source of evidence in the assessment of health interventions …

Keywords

Missing Data, Economic Evaluations

Abstract

Trial-based cost-effectiveness analyses (CEAs) are an important source of evidence in the assessment of health interventions. In these studies, cost and effectiveness outcomes are commonly measured at multiple time points, but some observations may be missing. Restricting the analysis to the participants with complete data can lead to biased and inefficient estimates. Methods, such as multiple imputation, have been recommended as they make better use of the data available and are valid under less restrictive Missing At Random (MAR) assumption. Linear mixed effects models (LMMs) offer a simple alternative to handle missing data under MAR without requiring imputations, and have not been very well explored in the CEA context. In this manuscript, we aim to familiarise readers with LMMs and demonstrate their implementation in CEA. We illustrate the approach on a randomised trial of antidepressant, and provide the implementation code in R and Stata. We hope that the more familiar statistical framework associated with LMMs, compared to other missing data approaches, will encourage their implementation and move practitioners away from inadequate methods.

 

Citation

BibTeX citation:
@online{gabrio2022,
  author = {Gabrio, Andrea and Plumpton, Catrin and Banerjee, Sube and
    Leurent, Baptiste},
  title = {Linear Mixed Models to Handle Missing at Random Data in
    Trial‐based Economic Evaluations},
  volume = {31},
  number = {6},
  date = {2022-04-10},
  url = {https://onlinelibrary.wiley.com/doi/full/10.1002/hec.4510},
  doi = {10.1002/hec.4510},
  langid = {en},
  abstract = {{[}Trial-based cost-effectiveness analyses (CEAs) are an
    important source of evidence in the assessment of health
    interventions ...{]}\{style=“font-size: 85\%”\}}
}
For attribution, please cite this work as:
Gabrio, Andrea, Catrin Plumpton, Sube Banerjee, and Baptiste Leurent. 2022. “Linear Mixed Models to Handle Missing at Random Data in Trial‐based Economic Evaluations.” Health Economics. April 10, 2022. https://doi.org/10.1002/hec.4510.